The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.20
Bid: 68.20
Ask: 69.40
Change: 0.00 (0.00%)
Spread: 1.20 (1.76%)
Open: 68.00
High: 68.20
Low: 68.00
Prev. Close: 68.20
GABI Live PriceLast checked at -
GCP Asset Backed Income is an Investment Trust

To generate attractive risk-adjusted returns through growing distributions and modest capital appreciation over the long term by investing in predominantly UK loans.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5(EPT/NON-RI)-GCP Asset Backed Income F Ltd

8 Mar 2024 11:14

RNS Number : 1795G
Barclays PLC
08 March 2024

FORM 8.5 (EPT/NON-RI)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS

(OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Name of exempt principal trader:

BARCLAYS CAPITAL SECURITIES LTD

(b)

Name of offeror/offeree in relation to whose relevant securities this form relates:

GCP ASSET BACKED INCOME FUND LTD

(c)

Name of the party to the offer with which exempt principal trader is connected

GCP ASSET BACKED INCOME FUND LTD

(d)

Date position held/dealing undertaken:

07 Mar 2024

(e)

In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

NO

2.

POSITIONS OF THE EXEMPT PRINCIPAL TRADER

(a)

Interests and short positions in the relevant securities of the offeror or offeree

to which the disclosure relates following the dealing (if any)

Class of relevant security:

NPV ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1) Relevant securities owned and/or controlled:

321,937

0.08%

0

0.00%

(2) Cash-settled derivatives:

0

0.00%

44,355

0.01%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

321,937

0.08%

44,355

0.01%

(b)

Rights to subscribe for new securities (including directors and other executive options)

Class of relevant security in relation to which subscription right exists

Details, including nature of the rights concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchase and sales

Class of relevant security

Purchase/sale

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

NPV ordinary

Purchase

6278

0.6880 GBP

0.6859 GBP

NPV ordinary

Sale

6390

0.6879 GBP

0.6879 GBP

(b)

Cash-settled derivative transactions

Class of relevant security

Product description

Nature of dealing

Number of reference securities

Price per unit

NPV ordinary

SWAP

Decreasing Short

279

0.6871 GBP

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class of relevant security

Product description

Writing, purchasing, selling, varying etc

Number of securities to which option relates

Exercise price per unit

Type

Expiry date

Option money paid/ received per unit

(ii)

Exercising

Class of relevant security

Product description

Exercising/ exercised against

Number of securities

Exercise price per unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant security

Nature of Dealings

Details

Price per unit (if applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights of future acquisition or disposal of any relevant securities to which any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

08 Mar 2024

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FEOQKFBDDBKDKNK
Date   Source Headline
19th Oct 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
19th Oct 20207:00 amRNSTransaction in Own Shares
16th Oct 20207:00 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value and Investment Update
15th Oct 20207:00 amRNSTransaction in Own Shares
12th Oct 20207:00 amRNSTransaction in Own Shares
8th Oct 20207:00 amRNSTransaction in Own Shares
7th Oct 20207:00 amRNSTransaction in Own Shares
10th Sep 20207:00 amRNSHalf-Yearly Report & Financial Statements
31st Jul 20207:00 amRNSInvestor Report as at 30 June 2020
23rd Jul 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
15th Jul 20204:42 pmRNSSecond Price Monitoring Extn
15th Jul 20204:38 pmRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSNet Asset Value and Investment Update
10th Jul 20207:00 amRNSExtension to term of Revolving Credit Facility
7th Jul 20204:22 pmRNSResult of AGM & EGM
17th Jun 20204:36 pmRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
26th May 20207:00 amRNSTransaction in Own Shares
22nd May 20207:00 amRNSTransaction in Own Shares
20th May 20204:41 pmRNSSecond Price Monitoring Extn
20th May 20204:37 pmRNSPrice Monitoring Extension
20th May 20207:00 amRNSNotices of AGM & EGM
4th May 20207:00 amRNSInvestor Report as at 31 March 2020
29th Apr 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
21st Apr 20207:00 amRNSNet Asset Value and Investment Update
7th Apr 20207:00 amRNSAnnual Report & AGM
31st Mar 20207:00 amRNSTotal Voting Rights
25th Mar 20207:00 amRNSTransaction in Own Shares
24th Mar 20207:00 amRNSTransaction in Own Shares
20th Mar 20207:00 amRNSTransaction in Own Shares
19th Mar 20207:00 amRNSAnnual Report & Financial Statements
19th Mar 20207:00 amRNSTransaction in Own Shares
18th Mar 20207:00 amRNSCompliance with Market Abuse Regulation
28th Feb 20209:47 amRNSTotal Voting Rights & Additional Listing
21st Feb 20207:00 amRNSAdditional Listing
17th Feb 20207:00 amRNSInvestment in co-living
6th Feb 20207:00 amRNSScrip Share Reference Price
30th Jan 20207:00 amRNSInvestor report as at 31 December 2019
29th Jan 20207:00 amRNSChange of corporate adviser
22nd Jan 20207:00 amRNSDividend Declaration & Scrip Dividend Alternative
16th Jan 20207:00 amRNSNet Asset Value
16th Jan 20207:00 amRNSRevolving Credit Facility
29th Nov 20199:34 amRNSTotal Voting Rights and Additional Listing
25th Nov 20197:00 amRNSAdditional Listing
7th Nov 201910:08 amRNSScrip Share Reference Price
7th Nov 20197:00 amRNSDirectorate Change
31st Oct 20197:00 amRNSInvestor Report as at 30 September 2019
23rd Oct 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.